Ainos, Inc, formerly Amarillo Biosciences, Inc., is a diversified healthcare company. The Company is engaged in the discovery and development of pharmaceutical and biotechnology products. The Company focuses on point-of-care testing rapid test kit products that include diagnostics for Coronavirus disease (COVID-19), pneumonia, vaginal infection and helicobacter pylori (H. pylori) bacterial infection. It offers products for the human body to combat disease and enhance the ability to heal.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)